AI-Powered Primary Care Disrupts European Healthcare, Secures €36M Total Series A
December 17, 2025, 9:47 pm
Jutro Medical, a Warsaw-based AI-first primary care operator, secured €24 million in Series A extension funding. This brings its total Series A to €36 million. The capital fuels clinic acquisitions in Poland and broader European expansion. Jutro Medical integrates online and in-person care. It utilizes proprietary electronic health records and AI agents. These tools streamline administrative tasks. Clinicians gain more time for direct patient care. The company employs an acquisition-led strategy. It aims to consolidate Europe's fragmented primary care market. This innovative model addresses workforce shortages. It improves patient access across the continent. Jutro Medical positions itself as a future pan-European healthcare leader.
Jutro Medical, a pioneering AI-first primary care provider, recently fortified its financial position. The Warsaw-based entity secured an additional €24 million. This investment extends its Series A round. Total Series A funding now stands at €36 million. This substantial capital influx signals strong investor confidence. It targets expansion and technological advancement.
Leading the Series A extension was Warsaw Equity Group. Significant participation came from Vinci, naturalX Health Ventures, Fluent Ventures, Aternus, KAYA VC, and Inovo VC. Further financial support includes a debt component. This debt comes from mBank and Orbit Capital. The combined funding empowers Jutro Medical's ambitious vision.
Founded in 2020, Jutro Medical built an integrated primary care model. It seamlessly combines online and in-person care. A proprietary Electronic Health Record (EHR) system underpins operations. Standardized clinic workflows ensure consistent service. AI-based tools form a critical component of its strategy.
The company's initial four years focused on infrastructure. It prioritized building its EHR and foundational software. This groundwork established a robust data infrastructure. This careful development enabled efficient integration of AI. Artificial intelligence agents now perform administrative tasks. These include patient intake and drafting visit documentation. Clinicians access pre-populated patient contexts. They then review and adjust information. Critical clinical decisions remain with the human practitioner. Patient choice is paramount; traditional appointments are always available.
Jutro Medical's approach directly addresses systemic issues in primary care. Europe faces significant healthcare challenges. Workforce shortages persist. Administrative workloads burden medical staff. Access to care remains uneven. Annual primary care spending in Europe exceeds €200 billion. Poland alone accounts for approximately €9 billion. Yet, many clinics still rely on outdated, manual processes. These inefficiencies slow patient access and reduce capacity.
The company employs a distinctive acquisition-led strategy. This "rollup" model brings acquired clinics onto a unified platform. This shared operational and technological ecosystem standardizes care. It includes a common EHR, streamlined workflows, and integrated AI tools. This year, Jutro Medical added nine clinics to its network. It targets around 20 acquisitions annually. This strategy ensures service consistency and rapid integration.
AI agents manage thousands of patient interactions monthly. This automation frees clinicians. Doctors focus on practicing medicine. They spend less time on paperwork. This translates into more patient-centric care. The new capital will further advance AI development. Additional administrative and operational tasks will be automated. Clinicians will concentrate on diagnosis and treatment.
Jutro Medical claims a unique position in Europe. It asserts being the first operator to scale the AI rollup model in primary care. This innovative approach promises to redefine healthcare delivery. Its telemedicine platform offers comprehensive virtual services. These include consultations, prescriptions, referrals, and lab results. Online requests for medical leave are available for less complex cases. For urgent or complex needs, patients receive in-person care. They often see the same practitioner, ensuring continuity.
The company's unified operating model offers distinct advantages. By bringing clinics onto a single platform, it ensures consistent quality. This approach speeds up integration processes. It also improves margins across its expanding network.
Current performance metrics highlight Jutro Medical's success. It serves 120,000 patients across Poland. The company has conducted over 500,000 visits. Patients report high satisfaction. The average visit rating stands at 4.94 on a 1-5 scale. Its Net Promoter Score (NPS) is an impressive 86. The company boasts significant growth. Revenue nearly quadrupled year over year. EBITDA remains around break-even. This combination is rare in the market. Nearly 1,500 doctor visits were supported by AI in the past month. The company exhibits a 270% year-over-year growth rate.
This new funding will fuel continued expansion. Clinic acquisitions in Poland remain a priority. The company will also replicate its rollup model across other European markets. The long-term goal is ambitious: build a pan-European primary care operator. This involves consolidating a highly fragmented market. Thousands of small GP practices in Europe face retirement each year. This presents a significant market opportunity. Jutro Medical aims to capitalize on this trend.
The ultimate vision targets over €1 billion in revenue. Jutro Medical aspires to set a new standard for publicly funded care. Its model offers a compelling solution. It addresses the growing demand for efficient, accessible healthcare. By leveraging AI and strategic acquisitions, Jutro Medical is poised for substantial impact. Its trajectory suggests a significant transformation within European primary care.
Jutro Medical, a pioneering AI-first primary care provider, recently fortified its financial position. The Warsaw-based entity secured an additional €24 million. This investment extends its Series A round. Total Series A funding now stands at €36 million. This substantial capital influx signals strong investor confidence. It targets expansion and technological advancement.
Leading the Series A extension was Warsaw Equity Group. Significant participation came from Vinci, naturalX Health Ventures, Fluent Ventures, Aternus, KAYA VC, and Inovo VC. Further financial support includes a debt component. This debt comes from mBank and Orbit Capital. The combined funding empowers Jutro Medical's ambitious vision.
Founded in 2020, Jutro Medical built an integrated primary care model. It seamlessly combines online and in-person care. A proprietary Electronic Health Record (EHR) system underpins operations. Standardized clinic workflows ensure consistent service. AI-based tools form a critical component of its strategy.
The company's initial four years focused on infrastructure. It prioritized building its EHR and foundational software. This groundwork established a robust data infrastructure. This careful development enabled efficient integration of AI. Artificial intelligence agents now perform administrative tasks. These include patient intake and drafting visit documentation. Clinicians access pre-populated patient contexts. They then review and adjust information. Critical clinical decisions remain with the human practitioner. Patient choice is paramount; traditional appointments are always available.
Jutro Medical's approach directly addresses systemic issues in primary care. Europe faces significant healthcare challenges. Workforce shortages persist. Administrative workloads burden medical staff. Access to care remains uneven. Annual primary care spending in Europe exceeds €200 billion. Poland alone accounts for approximately €9 billion. Yet, many clinics still rely on outdated, manual processes. These inefficiencies slow patient access and reduce capacity.
The company employs a distinctive acquisition-led strategy. This "rollup" model brings acquired clinics onto a unified platform. This shared operational and technological ecosystem standardizes care. It includes a common EHR, streamlined workflows, and integrated AI tools. This year, Jutro Medical added nine clinics to its network. It targets around 20 acquisitions annually. This strategy ensures service consistency and rapid integration.
AI agents manage thousands of patient interactions monthly. This automation frees clinicians. Doctors focus on practicing medicine. They spend less time on paperwork. This translates into more patient-centric care. The new capital will further advance AI development. Additional administrative and operational tasks will be automated. Clinicians will concentrate on diagnosis and treatment.
Jutro Medical claims a unique position in Europe. It asserts being the first operator to scale the AI rollup model in primary care. This innovative approach promises to redefine healthcare delivery. Its telemedicine platform offers comprehensive virtual services. These include consultations, prescriptions, referrals, and lab results. Online requests for medical leave are available for less complex cases. For urgent or complex needs, patients receive in-person care. They often see the same practitioner, ensuring continuity.
The company's unified operating model offers distinct advantages. By bringing clinics onto a single platform, it ensures consistent quality. This approach speeds up integration processes. It also improves margins across its expanding network.
Current performance metrics highlight Jutro Medical's success. It serves 120,000 patients across Poland. The company has conducted over 500,000 visits. Patients report high satisfaction. The average visit rating stands at 4.94 on a 1-5 scale. Its Net Promoter Score (NPS) is an impressive 86. The company boasts significant growth. Revenue nearly quadrupled year over year. EBITDA remains around break-even. This combination is rare in the market. Nearly 1,500 doctor visits were supported by AI in the past month. The company exhibits a 270% year-over-year growth rate.
This new funding will fuel continued expansion. Clinic acquisitions in Poland remain a priority. The company will also replicate its rollup model across other European markets. The long-term goal is ambitious: build a pan-European primary care operator. This involves consolidating a highly fragmented market. Thousands of small GP practices in Europe face retirement each year. This presents a significant market opportunity. Jutro Medical aims to capitalize on this trend.
The ultimate vision targets over €1 billion in revenue. Jutro Medical aspires to set a new standard for publicly funded care. Its model offers a compelling solution. It addresses the growing demand for efficient, accessible healthcare. By leveraging AI and strategic acquisitions, Jutro Medical is poised for substantial impact. Its trajectory suggests a significant transformation within European primary care.